| Latest | F'cast | |
|---|---|---|
| Div Yield | 1.4% | |
| Div Cover | 3.8 | |
| Op Mrgn | 9.1% | |
| ROCE | 8.2% |
| Latest | F'cast | |
|---|---|---|
| P/E | 19.2 | |
| PEG | 1.7 | |
| Pr/Revenue | 0.4 | |
| Pr/Book | 0.9 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 11.2% | |
| PBT | 10.7% | |
| EPS | 11.4% | |
| DPS | 9.5% |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 919.90 | (231.00) | (5.20)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | 1,106.20 | (1.90) | (7.10)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 1,198.50 | 3.90 | 4.20p | 54.5 | n/a | n/a | 0.50p | 0.2% |
| 31-Dec-23 | 1,359.00 | 34.60 | 7.90p | 28.5 | 0.3 | +88% | 2.10p | 0.9% |
| 31-Dec-24 | 1,511.20 | 38.30 | 8.80p | 25.6 | 2.3 | +11% | 2.30p | 1.0% |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-25 | 1,593.44 | 158.29 | 9.35p | 18.1 | 2.9 | +6% | 2.56p | 0.0% |
| 31-Dec-26 | 1,672.29 | 176.65 | 13.38p | 12.6 | 0.3 | +43% | 3.79p | 0.0% |
| 31-Dec-27 | 1,764.70 | 203.31 | 18.26p | 9.3 | 0.3 | +36% | 5.08p | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
| Form 8.3 - The Vanguard Group, Inc.: Spire Healt... | 09-Dec-2025 | 14:41 | EQS Group |
| Form 8.3 - The Vanguard Group, Inc.: Spire Healt... | 08-Dec-2025 | 14:44 | EQS Group |
| Form 8.3 - The Vanguard Group, Inc.: Spire Healt... | 05-Dec-2025 | 14:44 | EQS Group |
No recent information was found.
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 169.10p |
| Change Today | -0.043p |
| % Change | -2.48 % |
| 52 Week High | 248.50 |
| 52 Week Low | 168.80 |
| Volume | 517,103 |
| Shares Issued | 399.39m |
| Market Cap | £675.37m |
| Strong Buy | 4 |
| Buy | 1 |
| Neutral | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 6 |

| Time | Volume / Share Price |
| 16:29 | 9 @ 169.10p |
| 16:27 | 545 @ 169.00p |
| 16:25 | 103 @ 168.80p |
| 16:17 | 3,000 @ 169.10p |
| 16:15 | 485 @ 169.20p |
| CEO | Justin Ash |
| CFO | Harbant Samra |
You are here: research